Home Recalls D-620-2013
Class II · Moderate risk Terminated Initiated May 3, 2013 (13 years ago)
Pure-Aid Allergy Relief, Diphenhydramine HCL Caplets, 25 mg, 20 caplets, Exclusively…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Labeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredient as Chlorpheniramine rather than Diphenhydramine
What was recalled
Pure-Aid Allergy Relief, Diphenhydramine HCL Caplets, 25 mg, 20 caplets, Exclusively distributed by: Kareway Products Inc., Compton, CA --- UPC 8 56023 00158 2
Recalling firm Kareway Product Inc
Origin CA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-620-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Diphenhydramine recalls
See all
Class II · Moderate risk Ongoing Mar 26, 2025
Reason CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA…
Class II · Moderate risk Ongoing Mar 4, 2025
Reason CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug…
Class III · Low risk Ongoing Dec 12, 2024
Reason Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Class III · Low risk Ongoing Dec 12, 2024
Reason Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Class III · Low risk Ongoing Dec 12, 2024
Reason Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.